Targeted contrast-enhanced ultrasound: An emerging technology in abdominal and pelvic imaging

Gastroenterology

Volumn 140, Issue 3, 2011, Pages

  Pysz, Marybeth A ^a   Willmann, Jürgen K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECHO CONTRAST MEDIUM; GADOLINIUM;

ABDOMINAL CANCER; ABDOMINAL CAVITY INFLAMMATION; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; ECHOGRAPHY; ENTERITIS; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; IMAGE DISPLAY; IMAGE QUALITY; MEDICAL TECHNOLOGY; MICROBUBBLE; MOLECULAR BIOLOGY; MOLECULAR DIAGNOSIS; MOLECULAR GENETICS; MOLECULAR IMAGING; NONHUMAN; PATIENT SAFETY; PELVIC INFLAMMATORY DISEASE; PELVIS CANCER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING;

EID: 79952298688     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.01.027     Document Type: Article

References (61)

1. M.A. Pysz, S.S. Gambhir, and J.K. Willmann Molecular imaging: current status and emerging strategies Clin Radiol 65 2010 500 516
2. M.A. Pysz, K. Foygel, and J. Rosenberg Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55) Radiology 256 2010 519 527
3. I. Tardy, S. Pochon, and M. Theraulaz Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55 Invest Radiol 45 2010 573 578
4. N. Deshpande, A. Needles, and J.K. Willmann Molecular ultrasound imaging: current status and future directions Clin Radiol 65 2010 567 581
5. J.K. Willmann, R.H. Kimura, and N. Deshpande Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides J Nucl Med 51 2010 433 440
6. F. Kiessling Science to practice: the dawn of molecular US imaging for clinical cancer imaging Radiology 256 2010 331 333
7. S.R. Wilson, and P.N. Burns Microbubble-enhanced US in body imaging: what role? Radiology 257 2010 24 39
8. S.R. Wilson, H.J. Jang, and T.K. Kim Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography AJR Am J Roentgenol 190 2008 691 695 (Pubitemid 351304513)
9. N. Deshpande, M.A. Pysz, and J.K. Willmann Molecular ultrasound assessment of tumor angiogenesis Angiogenesis 13 2010 175 188
10. J.K. Willmann, N. van Bruggen, and L.M. Dinkelborg Molecular imaging in drug development Nat Rev Drug Discov 7 2008 591 607 (Pubitemid 351927724)
11. A.L. Klibanov Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging Bioconjug Chem 16 2005 9 17 (Pubitemid 40129671)
12. A.L. Klibanov Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging Med Biol Eng Comput 47 2009 875 882
13. J.K. Willmann, Z. Cheng, and C. Davis Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice Radiology 249 2008 212 219
14. M. Blomley, M. Claudon, and D. Cosgrove WFUMB Safety Symposium on Ultrasound Contrast Agents: clinical applications and safety concerns Ultrasound Med Biol 33 2007 180 186 (Pubitemid 46240590)
15. D. Bhayana, T.K. Kim, and H.J. Jang Hypervascular liver masses on contrast-enhanced ultrasound: the importance of washout AJR Am J Roentgenol 194 2010 977 983
16. M. Brannigan, P.N. Burns, and S.R. Wilson Blood flow patterns in focal liver lesions at microbubble-enhanced US Radiographics 24 2004 921 935 (Pubitemid 38943326)
17. C. Gorg The forgotten organ: contrast enhanced sonography of the spleen Eur J Radiol 64 2007 189 201 (Pubitemid 47593064)
18. K. Nylund, T. Hausken, and O.H. Gilja Ultrasound and inflammatory bowel disease Ultrasound Q 26 2010 3 15
19. K. Nylund, S. Odegaard, and T. Hausken Sonography of the small intestine World J Gastroenterol 15 2009 1319 1330
20. B.D. Doust The use of ultrasound in the diagnosis of gastroenterological disease Gastroenterology 70 1976 602 610
21. P. Fusaroli, A. Spada, and M.G. Mancino Contrast harmonic echo-endoscopic ultrasound improves accuracy in diagnosis of solid pancreatic masses Clin Gastroenterol Hepatol 8 2010 629 634
22. L. Helmstaedter, and J.F. Riemann Pancreatic cancerEUS and early diagnosis Langenbecks Arch Surg 393 2008 923 927
23. C. Hohl, T. Schmidt, and D. Honnef Ultrasonography of the pancreas. 2 Harmonic imaging Abdom Imaging 32 2007 150 160
24. T.P. Kinney, and M.L. Freeman Pancreatic imaging: current state of the art Gastroenterology 136 2009 776 779
25. R.J. Nair, L. Lawler, and M.R. Miller Chronic pancreatitis Am Fam Physician 76 2007 1679 1688
26. S. Rickes, K. Monkemuller, and P. Malfertheiner Acute severe pancreatitis: contrast-enhanced sonography Abdom Imaging 32 2007 362 364 (Pubitemid 47077105)
27. S. Rickes, P. Rauh, and C. Uhle Contrast-enhanced sonography in pancreatic diseases Eur J Radiol 64 2007 183 188 (Pubitemid 47588754)
28. A. Saftoiu, and P. Vilmann Role of endoscopic ultrasound in the diagnosis and staging of pancreatic cancer J Clin Ultrasound 37 2009 1 17
29. A. Seicean, R. Badea, and R. Stan-Iuga The added value of real-time harmonics contrast-enhanced endoscopic ultrasonography for the characterisation of pancreatic diseases in routine practice J Gastrointest Liver Dis 19 2010 99 104
30. N. Lassau, S. Koscielny, and L. Albiges Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography Clin Cancer Res 16 2010 1216 1225
31. J.M. Correas, M. Claudon, and F. Tranquart The kidney: imaging with microbubble contrast agents Ultrasound Q 22 2006 53 66 (Pubitemid 44510228)
32. C. Hoeffel, M. Pousset, and M.O. Timsit Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour Eur Radiol 20 2010 1812 1821
33. Z.F. Xu, H.X. Xu, and X.Y. Xie Renal cell carcinoma and renal angiomyolipoma: differential diagnosis with real-time contrast-enhanced ultrasonography J Ultrasound Med 29 2010 709 717
34. P.D. DePriest, and C.P. DeSimone Ultrasound screening for the early detection of ovarian cancer J Clin Oncol 21 2003 194s 199s
35. A.C. Fleischer, A. Lyshchik, and R.F. Andreotti Advances in sonographic detection of ovarian cancer: depiction of tumor neovascularity with microbubbles AJR Am J Roentgenol 194 2010 343 348
36. A.C. Fleischer, A. Lyshchik, and H.W. Jones Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonography J Ultrasound Med 28 2009 1273 1280
37. D.L. Clarke-Pearson Clinical practice Screening for ovarian cancer N Engl J Med 361 2009 170 177
38. F. Aigner, M. Mitterberger, and P. Rehder Status of transrectal ultrasound imaging of the prostate J Endourol 24 2010 685 691
39. F. Aigner, L. Pallwein, and M. Mitterberger Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate BJU Int 103 2009 458 463
40. N. Faccioli, S. Crippa, and C. Bassi Contrast-enhanced ultrasonography of the pancreas Pancreatology 9 2009 560 566
41. J.T. Dudley, and A.J. Butte Biomarker and drug discovery for gastroenterology through translational bioinformatics Gastroenterology 139 2010 735 741
42. J.K. Willmann, A.M. Lutz, and R. Paulmurugan Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo Radiology 248 2008 936 944
43. J.K. Willmann, R. Paulmurugan, and K. Chen US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice Radiology 246 2008 508 518
44. N. Deshpande, Y. Ren, and K. Foygel Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging Radiology 258 2011 804 811
45. C. Bachmann, A.L. Klibanov, and T.S. Olson Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease Gastroenterology 130 2006 8 16 (Pubitemid 43049830)
46. N. Deshpande, Y. Ren, and K. Foygel Quantification of inflammation in inflammatory bowel disease by molecular ultrasound imaging 2010 World Molecular Imaging Congress Kyoto, Japan Abstract # 0188
47. S. Pochon, I. Tardy, and P. Bussat BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis Invest Radiol 45 2010 89 95
48. S. Tinkov, R. Bekeredjian, and G. Winter Microbubbles as ultrasound triggered drug carriers J Pharm Sci 98 2009 1935 1961
49. K. Ferrara, R. Pollard, and M. Borden Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery Annu Rev Biomed Eng 9 2007 415 447 (Pubitemid 350246663)
50. A. Ignee, M. Jedrejczyk, and G. Schuessler Quantitative contrast enhanced ultrasound of the liver for time intensity curvesreliability and potential sources of errors Eur J Radiol 73 2010 153 158
51. M. Lamuraglia, S.L. Bridal, and M. Santin Clinical relevance of contrast-enhanced ultrasound in monitoring anti-angiogenic therapy of cancer: current status and perspectives Crit Rev Oncol Hematol 73 2010 202 212
52. M.A. Pysz, K. Foygel, and C.M. Panje Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging Invest Radiol 46 2011 187 195
53. M. Palmowski, W. Lederle, and J. Gaetjens Comparison of conventional time-intensity curves vs. maximum intensity over time for post-processing of dynamic contrast-enhanced ultrasound Eur J Radiol 75 2010 e149 e153
54. K. Wei, A.R. Jayaweera, and S. Firoozan Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion Circulation 97 1998 473 483 (Pubitemid 28090220)
55. M. Arditi, P.J. Frinking, and X. Zhou A new formalism for the quantification of tissue perfusion by the destruction-replenishment method in contrast ultrasound imaging IEEE Trans Ultrason Ferroelectr Freq Control 53 2006 1118 1129 (Pubitemid 46405092)
56. J. Gao, S. Huang, and M. Li GM-CSF-surface-modified B16.F10 melanoma cell vaccine Vaccine 24 2006 5265 5268 (Pubitemid 43818206)
57. D. Marshall, R.B. Pedley, and J.A. Boden Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody Br J Cancer 73 1996 565 572 (Pubitemid 26068858)
58. D.L. Meyer, J. Schultz, and Y. Lin Reduced antibody response to streptavidin through site-directed mutagenesis Protein Sci 10 2001 491 503 (Pubitemid 32221140)
59. R. Pillai, E.R. Marinelli, and H. Fan A phospholipid-PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeting heterodimer peptide for contrast-enhanced ultrasound imaging of angiogenesis Bioconjug Chem 21 2010 556 562
60. R. Pillai, E.R. Marinelli, and R.E. Swenson A flexible method for preparation of peptide homo- and heterodimers functionalized with affinity probes, chelating ligands, and latent conjugating groups Biopolymers 84 2006 576 585 (Pubitemid 44935257)
61. A. Shrivastava, and M.A. von Wronski A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases Protein Eng Des Sel 18 2005 417 424 (Pubitemid 41219888)